Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 01)
Fosinopril Sodium Tablet
Product Images NDC 69097-858
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 69097-858). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 02)
This is a table showing the incidence of clinical adverse events in patients with hypertension who were in placebo-controlled trials for Fosinopril Sodium. The table compares the incidence and discontinuation rates of the adverse events in patients taking Fosinopril Sodium versus patients taking a placebo. The adverse events listed are cough, dizziness, and nausea/vomiting.*
Image (9d869f7c 9b5a 47aa 9a82 35a0f86112b2 03)
This is a list of clinical adverse events documented in placebo-controlled trials related to heart failure for a medication called Fosinopril Sodium. These events include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, diarrhea, chest pain (non-cardiac), upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbances, and weakness. The table shows the incidence of these events and the rate of discontinuation for Fosinopril Sodium compared to placebo.*
Image (Fosinopril Label 10mg)
Each tablet contains 10mg of Estesfene, a medication used to treat high blood pressure. It is only available with a prescription and should be stored at room temperature, protected from moisture. The usual dosage should be determined by consulting the package insert. The tablets come in a child-resistant container and should be kept out of reach of children. This medication is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla Ltd, and is distributed by Cipla USA, Inc. The lot number, manufacturing date, and expiration date are also provided.*
Image (Fosinopril Label 20mg)
This is a description of a prescription drug called "Blemirtcs" with the active ingredient "OSINOPril" and a strength of "oo mg". The packaging contains 90 tablets with a child-resistant closure and the National Drug Code (NDC) is 69057-857-05. The dosage information is included in the package insert. The manufacturer is InvaTech Pharmaceuticals Inc. and the drug is distributed by Cipla USA Inc. It is important to keep this medication out of the reach of children.*
Image (Fosinopril Label 40mg)
This is a description of a medication called Fosinopril Sodium, USP in tablet form. Each tablet contains 40 mg and should be stored at room temperature. The medication should be dispensed in a child-resistant container and kept out of the reach of children. The standard dosage information can be found in the package insert. The medication is manufactured by InvaGen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd., and is distributed via Cipla USA, Inc. in Hauppauge, NY. The description also includes a GTIN and SN number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
